NASDAQ:COGT
Cogent Biosciences, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.cogentbio.comipo date
Mar 29, 2018
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastroi...Show More
Earnings
Earnings Release in 10 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus